Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-20 @ 6:25 PM
Study NCT ID:
NCT03078751
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2017-02-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-09
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-27
First Submit QC Date:
None
Study First Post Date:
2017-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-12-21
Results First Submit QC Date:
None
Results First Post Date:
2021-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL